Toll-like receptor (TLR)-9 genetics and function in sarcoidosis

被引:29
|
作者
Veltkamp, M. [1 ]
van Moorsel, C. H. M. [1 ,3 ]
Rijkers, G. T. [2 ]
Ruven, H. J. T. [3 ]
van den Bosch, J. M. M. [1 ,4 ]
Grutters, J. C. [1 ,4 ]
机构
[1] St Antonius Hosp, Dept Pulmonol, Ctr Interstitial Lung Dis, NL-3430 EM Nieuwegein, Netherlands
[2] St Antonius Hosp, Dept Med Microbiol & Immunol, NL-3430 EM Nieuwegein, Netherlands
[3] St Antonius Hosp, Dept Clin Chem, NL-3430 EM Nieuwegein, Netherlands
[4] Univ Utrecht, Med Ctr, Div Heart & Lungs, Utrecht, Netherlands
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2010年 / 162卷 / 01期
关键词
cytokine production; polymorphisms; sarcoidosis; Toll-like receptor-9; BLOOD MONONUCLEAR-CELLS; MYCOBACTERIAL CATALASE-PEROXIDASE; INTERFERON-GAMMA PRODUCTION; GREEK PATIENTS; POLYMORPHISMS; DNA; TLR9; EXPRESSION; PROPIONIBACTERIAL; ASSOCIATION;
D O I
10.1111/j.1365-2249.2010.04205.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>Sarcoidosis is a systemic disorder characterized by the formation of non-caseating granulomas in variable organs. Toll-like receptor (TLR)-9 is important in the innate immune response against both Mycobacterium tuberculosis and Propionibacterium acnes, candidate causative agents in sarcoidosis. The aim of our study was to investigate possible genetic and functional differences in TLR-9 between patients and controls. TLR-9 single nucleotide polymorphisms were genotyped in 533 patients and divided into a study cohort and validation cohort and 185 healthy controls. Furthermore, part of the promotor as well as the entire coding region of the TLR-9 gene were sequenced in 20 patients in order to detect new mutations. No genetic differences were found between patients and controls. In order to test TLR-9 function, peripheral blood mononuclear cells (PBMCs) of 12 healthy controls and 12 sarcoidosis patients were stimulated with a TLR-9 agonist and the induction of interleukin (IL)-6, interferon (IFN)-gamma and IL-23 was measured. Sarcoidosis patients produce significantly less IFN-gamma upon stimulation with different stimuli. Regarding IL-23 production, a significant difference between patients and controls was found only after stimulation with the TLR-9 agonist. In conclusion, we did not find genetic differences in the TLR-9 gene between sarcoidosis patients and controls. Sarcoidosis patients produce less IFN-gamma regardless of the stimulating agent, probably reflecting the anergic state often seen in their peripheral blood T lymphocytes. The differences in TLR-9-induced IL-23 production could indicate that functional defects in the TLR-9 pathway of sarcoidosis patients play a role in disease susceptibility or evolution.
引用
收藏
页码:68 / 74
页数:7
相关论文
共 50 条
  • [1] Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis
    Hamann, L
    Glaeser, C
    Hamprecht, A
    Gross, M
    Gomma, A
    Schumann, RR
    CLINICA CHIMICA ACTA, 2006, 364 (1-2) : 303 - 307
  • [2] Nicotine Treatment Improves Toll-Like Receptor 2 and Toll-Like Receptor 9 Responsiveness in Active Pulmonary Sarcoidosis
    Julian, Mark W.
    Shao, Guohong
    Schlesinger, Larry S.
    Huang, Qin
    Cosmar, David G.
    Bhatt, Nitin Y.
    Culver, Daniel A.
    Baughman, Robert P.
    Wood, Karen L.
    Crouser, Elliott D.
    CHEST, 2013, 143 (02) : 461 - 470
  • [3] Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus
    Demirci, F. Yesim K.
    Manzi, Susan
    Ramsey-Goldman, Rosalind
    Kenney, Margaret
    Shaw, Penny S.
    Dunlop-Thomas, Charmayne M.
    Kao, Amy H.
    Rhew, Elisa Y.
    Bontempo, Franklin
    Kammerer, Candace
    Kamboh, M. Ilyas
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (08) : 1708 - 1711
  • [4] Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis
    Pabst, S
    Baumgarten, G
    Stremmel, A
    Lennarz, M
    Knüfermann, P
    Gillissen, A
    Vetter, H
    Grohé, C
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 143 (03): : 420 - 426
  • [5] Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
    A M Krieg
    Oncogene, 2008, 27 : 161 - 167
  • [6] Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
    Krieg, A. M.
    ONCOGENE, 2008, 27 (02) : 161 - 167
  • [7] Polymorphism of Toll-like receptor 9 (TLR9) gene in sheep
    Zhou, Huitong
    Hickford, Jon G. H.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2008, 121 (1-2) : 140 - 143
  • [8] Regulation and function of toll-like receptor 9 in macrophages
    Sweet, Matthew J.
    Schroder, Kate
    Sester, David P.
    Trieu, Angela
    Rehli, Michael
    Risvanathan, Kumar
    Stacey, Katryn J.
    Hume, David A.
    INFLAMMATION RESEARCH, 2005, 54 : S186 - S186
  • [9] SYNAPTIC ABNORMALITIES OF MICE LACKING TOLL-LIKE RECEPTOR (TLR)-9
    Patel, V.
    Patel, A. M.
    McArdle, J. J.
    NEUROSCIENCE, 2016, 324 : 1 - 10
  • [10] Toll-like receptor 9 processing: The key event in Toll-like receptor 9 activation?
    Bauer, Stefan
    IMMUNOLOGY LETTERS, 2013, 149 (1-2) : 85 - 87